Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)
14.57
-0.27 (-1.82%)
Apr 24, 2026, 3:04 PM CST
SHE:300003 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 |
Operating Revenue | 6,280 | 6,344 | 6,059 | 7,916 | 10,553 | 10,613 |
Other Revenue | 138.99 | 138.99 | 44.2 | 64.24 | 56.93 | 46.74 |
| 6,419 | 6,483 | 6,103 | 7,980 | 10,609 | 10,660 | |
Revenue Growth (YoY) | 8.47% | 6.22% | -23.52% | -24.79% | -0.47% | 32.61% |
Cost of Revenue | 2,455 | 2,445 | 2,556 | 2,982 | 4,021 | 4,166 |
Gross Profit | 3,963 | 4,038 | 3,547 | 4,998 | 6,588 | 6,494 |
Selling, General & Admin | 1,816 | 1,878 | 2,236 | 2,440 | 2,776 | 2,858 |
Research & Development | 829.6 | 792.38 | 769.56 | 879.42 | 957.06 | 907.94 |
Other Operating Expenses | 97.7 | 69.43 | 63.28 | 58.37 | 33.9 | 103.14 |
Operating Expenses | 2,785 | 2,779 | 3,119 | 3,404 | 3,793 | 3,882 |
Operating Income | 1,178 | 1,259 | 427.99 | 1,594 | 2,795 | 2,612 |
Interest Expense | -279.28 | -176.64 | -181 | -170.65 | -188.78 | -228.49 |
Interest & Investment Income | 103.38 | 120.96 | 115.51 | 115.34 | 87.99 | 57.59 |
Currency Exchange Gain (Loss) | -49.71 | -49.71 | 26.91 | -25.38 | 16.14 | 6.58 |
Other Non Operating Income (Expenses) | -37.01 | -31.3 | -34.13 | -4.22 | -25.77 | -79.03 |
EBT Excluding Unusual Items | 915.55 | 1,122 | 355.29 | 1,509 | 2,684 | 2,368 |
Impairment of Goodwill | - | - | -62.95 | -33.45 | - | - |
Gain (Loss) on Sale of Investments | 0.48 | 1.55 | -89.32 | -13.44 | -70.91 | -367.54 |
Gain (Loss) on Sale of Assets | 5.17 | 4.87 | 11.73 | -4.07 | 0.02 | 19.9 |
Asset Writedown | -38.14 | -39.62 | -65.5 | -6.93 | -1.72 | -2.39 |
Other Unusual Items | 126.9 | 126.9 | 76.52 | 103.55 | - | 127.71 |
Pretax Income | 1,010 | 1,216 | 225.76 | 1,554 | 2,612 | 2,146 |
Income Tax Expense | 144.98 | 197.07 | 28.47 | 262.15 | 365.73 | 365.73 |
Earnings From Continuing Operations | 864.98 | 1,019 | 197.29 | 1,292 | 2,246 | 1,780 |
Minority Interest in Earnings | -34.7 | -57 | 49.64 | -34.15 | -42.28 | -61.09 |
Net Income | 830.28 | 962.01 | 246.94 | 1,258 | 2,204 | 1,719 |
Net Income to Common | 830.28 | 962.01 | 246.94 | 1,258 | 2,204 | 1,719 |
Net Income Growth | 478.16% | 289.57% | -80.37% | -42.91% | 28.18% | -4.58% |
Shares Outstanding (Basic) | 1,843 | 1,843 | 1,848 | 1,862 | 1,802 | 1,792 |
Shares Outstanding (Diluted) | 1,843 | 1,843 | 1,848 | 1,862 | 1,817 | 1,808 |
Shares Change (YoY) | -0.10% | -0.27% | -0.74% | 2.48% | 0.50% | 1.75% |
EPS (Basic) | 0.45 | 0.52 | 0.13 | 0.68 | 1.22 | 0.96 |
EPS (Diluted) | 0.45 | 0.52 | 0.13 | 0.68 | 1.21 | 0.95 |
EPS Growth | 478.71% | 290.64% | -80.23% | -44.29% | 27.54% | -6.22% |
Free Cash Flow | 612.61 | 873.86 | 75.82 | 145.69 | 1,885 | 2,078 |
Free Cash Flow Per Share | 0.33 | 0.47 | 0.04 | 0.08 | 1.04 | 1.15 |
Dividend Per Share | 0.326 | 0.326 | 0.277 | 0.331 | 0.341 | 0.275 |
Dividend Growth | 17.51% | 17.51% | -16.42% | -2.81% | 24.00% | 20.61% |
Gross Margin | 61.75% | 62.28% | 58.12% | 62.63% | 62.10% | 60.92% |
Operating Margin | 18.36% | 19.42% | 7.01% | 19.97% | 26.34% | 24.50% |
Profit Margin | 12.94% | 14.84% | 4.05% | 15.77% | 20.77% | 16.13% |
Free Cash Flow Margin | 9.54% | 13.48% | 1.24% | 1.83% | 17.77% | 19.49% |
EBITDA | - | 1,841 | 927.05 | 2,040 | 3,205 | 3,004 |
EBITDA Margin | - | 28.40% | 15.19% | 25.57% | 30.21% | 28.18% |
D&A For EBITDA | - | 581.89 | 499.06 | 446.75 | 410.11 | 392.37 |
EBIT | 1,178 | 1,259 | 427.99 | 1,594 | 2,795 | 2,612 |
EBIT Margin | 18.36% | 19.42% | 7.01% | 19.97% | 26.34% | 24.50% |
Effective Tax Rate | 14.36% | 16.21% | 12.61% | 16.86% | 14.00% | 17.04% |
Revenue as Reported | 6,419 | 6,483 | 6,103 | 7,980 | 10,609 | 10,660 |
Advertising Expenses | - | 20.19 | 28.49 | 84.23 | 60.08 | 76.04 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.